Search Results

Dispensing of anxiolytics and hypnotics in southeastern France: demographic factors and determinants of geographic variations

Authors: Bocquier, Aurélie; Bezzou, Kamel; Nauleau, Steve; Verger, Pierre

Source: Fundamental & Clinical Pharmacology, Volume 22, Number 3, June 2008 , pp. 323-333(11)

Publisher: Blackwell Publishing

Diagnosis and Treatment of Agoraphobia with Panic Disorder

Authors: Perugi, Giulio; Frare, Franco; Toni, Cristina

Source: CNS Drugs, Volume 21, Number 9, 2007 , pp. 741-764(24)

Publisher: Adis International

Therapeutic Potential of Kava in the Treatment of Anxiety Disorders

Authors: Singh Y.N.; Singh N.N.

Source: CNS Drugs, Volume 16, Number 11, 2002 , pp. 731-743(13)

Publisher: Adis International

Can the Behaviour Abnormalities Induced by Gestational Stress in Rats be Prevented or Reversed?

Author: Weinstock M.

Source: Stress, Volume 5, Number 3, 1 January 2002 , pp. 167-176(10)

Publisher: Informa Healthcare

Intrathecal baclofen for severe tetanus in a pregnant woman

Authors: Engrand, N.; Van de Perre, P.; Vilain, G.; Benhamou, D.

Source: European Journal of Anaesthesiology, Volume 18, Number 4, April 2001 , pp. 261-263(3)

Publisher: Blackwell Publishing

The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature

Authors: Weinbroum A.A.; Szold O.; Ogorek D.; Flaishon R.

Source: European Journal of Anaesthesiology, Volume 18, Number 12, 1 December 2001 , pp. 789-797(9)

Publisher: Greenwich Medical Media

Clinical aspects of anxiety states in the elderly

Authors: Casacchia M.; Roncone R.

Source: FEBS Letters, Volume 5, Number 3, September 1995 , pp. 247-248(2)

Publisher: Elsevier

A double-blind, multicentre study in primary care comparing paroxetine and clomipramine in patients with depression with associated anxiety

Author: Hunter B.

Source: FEBS Letters, Volume 5, Number 3, September 1995 , pp. 309-309(1)

Publisher: Elsevier

Venlafaxine XR in the treatment of anxiety

Author: Hackett D.

Source: Acta Psychiatrica Scandinavica, Volume 102, Supplement 406, December 2000 , pp. 30-35(6)

Publisher: Blackwell Publishing

Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice

Authors: Zarrindast M.-R.; Homayoun H.; Babaie A.; Etminani A.; Gharib B.

Source: European Journal of Pharmacology, Volume 407, Number 1, 27 October 2000 , pp. 145-158(14)

Publisher: Elsevier

Substance dependence and the use of Pro re nata Anxiolytic/hypnotic drugs in a hospital setting

Authors: D'Mello D.A.; Lyon D.E.; Colenda C.C.; Fernandes C.L.

Source: Addictive Behaviors, Volume 25, Number 3, May 2000 , pp. 441-443(3)

Publisher: Elsevier

Are antidepressants all the same? Surveying the opinions of Australian psychiatrists

Authors: Hickie I.B.; Scott E.M.; Davenport T.A.

Source: Australian and New Zealand Journal of Psychiatry, Volume 33, Number 5, October 1999 , pp. 642-649(8)

Publisher: Blackwell Publishing

Is There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders? - behavioral studies with pigeons

Author: Griebel G.

Source: Pharmacology and Therapeutics, Volume 82, Number 1, April 1999 , pp. 1-61(61)

Publisher: Elsevier

Pasteur Euroconference on Future Therapies for an Anxious World

Authors: Briley M.; Fillion G.

Source: Expert Opinion on Investigational Drugs, Volume 7, Number 1, January 1998 , pp. 113-116(4)

Publisher: Informa Healthcare

Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice

Authors: Belzung C.; &unknown;9gmo A.

Source: European Journal of Pharmacology, Volume 323, Number 2, 4 April 1997 , pp. 133-136(4)

Publisher: Elsevier

Clinical aspects of anxiety states in the elderly

Authors: Casacchia M.; Roncone R.

Source: European Neuropsychopharmacology, Volume 5, Number 3, September 1995 , pp. 247-248(2)

Publisher: Elsevier

A double-blind, multicentre study in primary care comparing paroxetine and clomipramine in patients with depression with associated anxiety

Author: Hunter B.

Source: European Neuropsychopharmacology, Volume 5, Number 3, September 1995 , pp. 309-309(1)

Publisher: Elsevier

Would CCK-4 challenges be useful to predict anti-anxiety effects of non anti-panic drugs?

Authors: Boulenger J.P.; Jerabek I.; Cocirc teacute G.; Lavalleacute e Y.J.; Jolicoeur F.B.

Source: European Neuropsychopharmacology, Volume 5, Number 3, September 1995 , pp. 374-375(2)

Publisher: Elsevier

Young offender drug use: knowledge and perceptions of Juvenile Justice Centre youth workers

Authors: Howard, John; Zibert, Ernie

Source: Drug and Alcohol Review, Volume 13, Number 1, 1994 , pp. 47-55(9)

Publisher: Informa Healthcare